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 Th e transfer of pathogenic T cells by 
Okamoto and colleagues 7 also induced 
increased glomerular complement depo-
sition without clear changes in serum 
IgG levels, anti-dsDNA levels, or overall 
glomerular IgG deposition, measured 
semiquantitatively. Nonetheless, it is 
possible that the transferred T cells did 
enhance glomerular deposition of patho-
genic autoantibodies with higher affi  nity 
or of a more damaging IgG subclass. 
Potentially, these autoantibodies could be 
responsible for the increased complement 
deposition found in the mice that received 
the pathogenic eff ector CD4   +   T cells. 
 Th e study by Okamoto  et al. 7 brings us 
a step closer to understanding how a vari-
ety of mediators, including eff ector CD4   +  
T cells, form an unholy alliance to mediate 
injury in lupus nephritis. Th e ultimate 
goal of new treatments, more targeted 
therapy with fewer side eff ects, may be 
more diffi  cult in patients with severe lupus 
nephritis because of both the potential 
diversity of target autoantigens and the 
involvement of multiple arms of the eff ec-
tor immune response. Over the past few 
years there has been real progress in using 
newer treatments, in the form of therapies 
such as mycophenolate and belimumab. 10 
However, already it has been shown that 
targeting autoimmunity to a  single anti-
gen, dsDNA, is not a useful treatment, 
even though dsDNA was a logical candi-
date antigen. 10 Th e diversity of clinical 
presentations and histological pictures in 
lupus and lupus nephritis may mean that 
in the future, treatment might need to be 
tailored in some patients to predominantly 
target one arm of the immune response, 
or even a restricted range of antigens. Fur-
ther well-designed studies in relevant and 
well-characterized experimental models 
of disease based on careful observations in 
humans need to be performed, so that we 
can better understand the nature of eff ec-
tor responses in this at-times devastating 
and diffi  cult-to-treat human disease. 
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 The glomerular endothelium 
emerges as a key player in 
diabetic nephropathy 
 Simon C.  Satchell 1 
 The effects of diabetes on glomerular structure and particularly that of 
the glomerular capillary wall have been extensively documented. By 
correlation with clinical measurements, Weil and colleagues provide 
important insights into the functional significance of glomerular 
structural changes in type 2 diabetes. Podocyte detachment correlates 
with albumin-to-creatinine ratio, but less strongly than does loss of 
endothelial fenestrations, which also correlates with reduced 
glomerular filtration rate. The role of the glomerular endothelium in 
diabetic nephropathy demands further scrutiny. 
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 Th e glomerular fi ltration barrier is highly 
permeable to water and small molecules 
but maintains very low permeability to 
macromolecules. 1 Th ese characteristics 
are dependent on its unique three-layer 
structure. Glomerular endothelial cells are 
characterized by fenestrations, 60- to 80-
nm transcellular holes through the peri-
pheral cytoplasm, essential for high water 
permeability. 2 Th e glomerular basement 
membrane (GBM) separates glomerular 
endothelial cells from podocytes whose 
interdigitating foot processes are spanned 
by the slit diaphragm ( Figure 1 ). 
 Until recently, the presence of fenestra-
tions has meant that the glomerular 
endothelium has been considered to con-
tribute little to the barrier to macromol-
ecules. However, it is now appreciated that 
the luminal surface of the glomerular 
endothelium is covered with a glycocalyx, 
which forms a signifi cant permeability 
barrier. 1,3 Th e glycocalyx is a negatively 
charged hydrated mesh of cell-surface-
anchored proteoglycans and adsorbed 
proteins and glycosaminoglycans in 
dynamic equilibrium with the plasma. 4 
 Furthermore, the glomerular fi ltration 
barrier is now understood to function as 
an integrated whole: 1 disruption of the 
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macromolecular permeability of any one 
layer aff ects overall permeability, and cell –
 cell communication via soluble mediators 
within the glomerular fi ltration barrier 
modulates its behavior. For example, 
vascular endothelial growth factor (VEGF) 
is produced by podocytes and is critical to 
maintenance of the adjacent glomerular 
endothelium, including regulation of 
fenestrations. 2,5 In this context there has 
been an increasing interest in the glome-
rular endothelium and its contribution to 
glomerular fi ltration. 6 
 Th e classical histological features of dia-
betic nephropathy include mesangial 
expansion and GBM thickening accompa-
nied by podocyte foot process widening or 
 ‘ eff acement. ’ Later studies have investigated 
features including podocyte loss, but knowl-
edge of glomerular endothelial behavior in 
diabetic nephropathy is sparse. A recent 
study has examined podocyte detachment 
and loss of endothelial fenestrations along 
with functional parameters in type 1 diabe-
tes, 7 and Weil  et al. 8 (this issue) now provide 
detailed correlations between these 
ultrastructural parameters and glomerular 
filtration rate (GFR) and albumin-to-
creatinine ratio (ACR) in type 2 diabetes. 
 Weil  et al. studied Pima Indians with type 
2 diabetes, divided into normo-, micro-, and 
macroalbuminuric groups. 8 Clinical charac-
teristics and glomerular structural parame-
ters derived from light and electron 
microscopy on renal biopsies were compared 
between these groups, as well as a group of 
nondiabetic non-Pima-Indian controls. 
Macroalbuminuric subjects had a longer 
duration of diabetes and a higher HbA1c 
level than normoalbuminurics. GFR was 
signifi cantly higher in microalbuminuria 
than in the three other groups, but there were 
no signifi cant blood pressure diff erences. 
 As expected on the basis of previous stud-
ies, glomerular volume, fractional interstitial 
area, fractional mesangial area, and GBM 
width were all higher in diabetes and tended 
to increase with increasing albuminuria. All 
diabetics had a reduced fi ltration surface 
area density, while the total surface area was 
increased in microalbuminuria. 
 Podocyte numbers were reduced in dia-
betes, signifi cantly so in micro- and mac-
roalbuminuria. Similarly, filtration slit 
frequency was reduced, and foot process 
width increased, in microalbuminuria and 
more so in macroalbuminuria. Podocyte 
detachment was higher in all diabetic 
groups compared with controls (0.03 % ), 
increasing from 0.4 % in normoalbuminuria 
to 1.48 % in macroalbuminuria. In type 1 
diabetes, 22 % of the GBM was not 
covered by intact foot processes compared 
with 2 % of controls. 7 These values are 
higher than those obtained by Weil  et al. 8 
probably because the latter measured GBM 
completely devoid of podocytes, a more 
stringent measure. Nevertheless, a similar 
pattern of increasing detachment parallel-
ing increasing albuminuria emerged. 
 Th e proportion of fenestrated endo thelium 
was reduced from 43.5 % in controls to 27.4 % 
and 27.2 % in normo- and microalbuminuria, 
respectively, and further to 19.3 % in macro-
albuminuria. Th ese observations are compa-
rable to those in type 1 diabetes: 41 % in 
controls, 32 % in normo- and microalbu-
minuria, and 25 % in macroalbumin uria. 7 
Fenestration loss has also been observed in 
animal models of diabetes. 2 
 Comparing structural parameters within 
diabetic groups revealed multiple diff er-
ences between macro- and both micro- 
and normoalbuminuric groups in line with 
the above observations. However, although 
there were trends, there were no signifi cant 
diff erences between normo- and micro-
albuminuric groups. Th is suggests that the 
structural changes observed do not 
account for microalbuminuria, which may 
be related to structural differences not 
measured in this study (see below) or to 
hemodynamic eff ects: GFR was higher in 
micro- than in normoalbuminuria. 
 Correlations between clinical and 
glome rular parameters, including the 
data from all subject groups, are of parti-
cular interest. GFR had few signifi cant 
correlations but was correlated positively 
with glomerular volume and total surface 
area and negatively with mesangial 
area. GFR was positively correlated with 
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 Figure 1  |  The glomerular filtration barrier and its disruption in type 2 diabetes. ( a ) Schematic 
of the normal glomerular filtration barrier, consisting of fenestrated glomerular endothelium, 
glomerular basement membrane (GBM), and podocyte foot processes. The endothelium is 
covered by a layer of glycocalyx: a mesh of cell-surface-anchored proteoglycans (core proteins and 
carbohydrate side chains, predominantly heparan sulfate and chondroitin sulfate) and adsorbed 
plasma proteins and glycosaminoglycans. Vascular endothelial growth factor (VEGF) is produced 
by podocytes and acts to maintain the adjacent glomerular endothelium. ( b ) Disruption of the 
glomerular filtration barrier in type 2 diabetes as described by Weil  et al. 8 includes thickening of 
the GBM, podocyte foot process widening, and podocyte detachment. 7 The overall proportion of 
fenestrated endothelium is reduced, but, surprisingly, this is not seen opposite areas of podocyte 
detachment. Disruption of the endothelial glycocalyx is not demonstrated by Weil  et al. 8 but is 
strongly implicated. Data regarding bioavailability of VEGF in the diabetic glomerulus are conflicting, 
but one possibility is that an initial increase is followed by a decrease as the disease progresses. 
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percentage fenestrated endothelium but 
was not significantly correlated with 
podocyte detachment. Although models 
predict the importance of fenestrations for 
maintenance of GFR, this is only the sec-
ond study to provide direct evidence, the 
fi rst being a study in preeclampsia. 9 
 ACR, on the other hand, was correlated 
with classical features of diabetic neph-
ropathy including mesangial expansion 
and podocyte foot process widening. It was 
also correlated positively with podocyte 
detachment, but, counterintuitively, the 
correlation was less marked than that with 
foot process widening. Th is may be because 
podocyte detachment aff ected only a small 
proportion of the fi ltration surface com-
pared with foot process widening. 
 It is arguable, therefore, that measure-
ment of podocyte detachment adds little in 
assessment of podocyte damage; however, 
it does provide an important insight into 
the evolution of diabetic glomerulopathy, 
with podocyte detachment likely to be the 
end result of podocyte dysfunction. 
 ACR correlated more strongly with per-
centage fenestrated endothelium (nega-
tively in this case) than did podocyte 
detachment. Th is leads to the surprising 
conclusion that the state of the glomerular 
endothelium more closely refl ects both 
GFR and ACR than podocyte parameters. 
Th e relevance of fenestrations to GFR is 
easy to understand, but what of ACR? 
Reduction of fenestrations might be 
expected to lead to a reduced ACR, sug-
gesting that this parameter is an index of 
disruption of another component of the 
glomerular fi ltration barrier, and the most 
obvious candidate is the endothelial glyco-
calyx. Although this study provides no 
direct evidence of glycocalyx disruption, 
there is ample evidence from other work 
that this occurs in diabetes. 10 
 Although endothelial fenestrations cor-
related with various structural parameters, 
these did not include any of the podocyte 
parameters. Th is is despite the fact that 
comparisons between the four study groups 
showed that there are similar patterns of 
change in diabetes: podocyte detachment 
increased in normo- and microalbuminu-
ria to a similar extent, while fenestrated 
endothelium decreased to similar extents 
in both groups. Both changed further in 
macroalbuminuria. However, when Weil 
 et al. 8 investigated their samples further by 
measuring endothelial fenestration directly 
across the GBM from detached podocytes, 
they found no decrease. 
 What are the implications of this study? 
Firstly, do these observations threaten the 
paradigm of glomerular endothelial cell 
dependence on podocyte-produced 
VEGF? 2,5 A number of explanations for the 
discrepancy present themselves: (1) VEGF 
levels may be abnormally high in diabetic 
glomeruli, so podocyte detachment in this 
context does not necessarily mean reduced 
VEGF bioavailability; (2) the proportion of 
GBM totally denuded of podocytes was 
small (  1.48 % ), and therefore the majority 
of a given endothelial cell will still be adja-
cent to an area of GBM where podocyte 
cytoplasm is present; (3) there may be subtle 
fenestration abnormalities not detected in 
this study; and (4) the formation of fenestra-
tions may be at least as dependent on the 
ability of glome rular endothelial cells to 
respond to VEGF as on the ability of podo-
cytes to produce it. Indeed, this considera-
tion also raises the reverse question of 
whether podocyte dysfunction may be 
downstream of endothelial damage through 
disordered release of endothelial-cell medi-
ators. In type 1 diabetes fenestral density did 
correlate with podocyte GBM coverage. 7 
 Secondly, the glomerular endothelial con-
tribution to glomerular fi ltration barrier 
pathophysiology is greater than generally 
appreciated. Th e importance of fenestra-
tions is clearly demonstrated, and that of the 
glycocalyx is strongly implied. Th is study 
should stimulate more intensive investiga-
tion of glomerular endothelial dysfunction 
in diabetic nephropathy with a view to tar-
get therapies to its prevention and reversal. 
Investigating whether renin – angiotensin 
system blockade modifi es these study obser-
vations, and confi rming them in non-Pima-
Indian type 2 diabetics, are obvious next 
steps. Th e link that endothelial dysfunction 
provides between the glomerulus, proteinu-
ria, and systemic vascular disease in diabetes 
also demands further exploration. 
 Direct confi rmation of the importance 
of the glomerular endothelial glycocalyx 
will require studies using specialized 
fi xation and staining techniques to label 
the glycocalyx and investigate its relation-
ship with ACR. 4 Higher-resolution imag-
ing will reveal fenestration changes in 
more detail in terms of size, density, distri-
bution, and correlation with glycocalyx 
disturbance. 
 Th irdly, the discordance between ACR 
and GFR is consistent with other studies 
and the recognition that decline in renal 
function may be independent of protein-
uria. 11 Such observations imply that dif-
ferent mechanisms underlie protein uria 
and loss of GFR, so that early decline in 
GFR may be a better predictor of progres-
sive renal failure than proteinuria. Hence 
the correlations of a reduced GFR, includ-
ing, in this study, loss of fenestrations, 
may be more informative in understand-
ing progressive diabetic nephropathy. 
 Finally, these fi ndings in diabetic nephro-
pathy, in addition to those in pree clampsia, 9 
suggest that fenestration loss may be impor-
tant in other glomerular diseases. In the 
majority of cases this question has not yet 
been addressed, but observations in trans-
plant glomerulo pathy and in a range of ani-
mal models suggest that such investigations 
will be rewarding. 2 
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